Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Cash from Investing Activities of -$105000.0 for Q4 2025, down 98.11% year-over-year from -$5.6 million in Q4 2024, and down 69.35% quarter-over-quarter from -$62000.0 in Q3 2025.
Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Pulse Biosciences' Cash from Investing Activities history runs 11 years deep, the most recent figure standing at -$105000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 98.11% year-over-year to -$105000.0; the TTM figure through Dec 2025 stood at -$335000.0 (down 168.0% YoY), while the FY2025 annual figure was -$335000.0, down 168.0% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$105000.0, down from -$62000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $7.9 million in Q1 2021, with the low at -$279000.0 in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$44000.0 (2023), against an average of $329050.0.
- The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities jumped 99.3% in 2021, then tumbled 800.0% in 2025.
- Pulse Biosciences' Cash from Investing Activities stood at -$134000.0 in 2021, then surged by 69.4% to -$41000.0 in 2022, then declined by 4.88% to -$43000.0 in 2023, then dropped by 23.26% to -$53000.0 in 2024, then plunged by 98.11% to -$105000.0 in 2025.
- Business Quant data shows PLSE's Cash from Investing Activities at -$105000.0 in Q4 2025, -$62000.0 in Q3 2025, and -$123000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Sep 30, 2023 | -23,000.00 |
| Sep 30, 2023 | -23,000.00 |